Medicine
Addiction news, research, studies, and rapid health briefings. Visit Viral Vitalism for plain-language context, evidence boundaries, and related signals.
GLP-1 medications may do more than reduce appetite for food. Early clinical trials, real-world data, and preclinical research suggest they may also affect craving, reward, alcohol intake, and substance-use patterns - but the science is still developing.
VV Signal Score
57
Early or context-dependent
Research map
Research records connected to this topic through topic tags, source records, and timeline events.
GLP-1 analogues in the neurobiology of addiction
Review from 2025 in Review article, translated into key findings, limitations, and consumer relevance.
Why this appears: Shown as discovery context only because no accepted page-level relationship metadata was supplied.
Review article / 2025->
Once-Weekly Semaglutide in Adults With Alcohol Use Disorder
Randomized trial from 2025 in JAMA Psychiatry, translated into key findings, limitations, and consumer relevance.
Why this appears: Shown as discovery context only because no accepted page-level relationship metadata was supplied.
JAMA Psychiatry / 2025->
Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity
Randomized trial from 2026 in The Lancet, translated into key findings, limitations, and consumer relevance.
Why this appears: Shown as discovery context only because no accepted page-level relationship metadata was supplied.
The Lancet / 2026->
Association of semaglutide with reduced incidence and relapse of cannabis use disorder in real-world populations
Observational study from 2024 in Molecular Psychiatry, translated into key findings, limitations, and consumer relevance.
Why this appears: Shown as discovery context only because no accepted page-level relationship metadata was supplied.
Molecular Psychiatry / 2024->
Vital Signals
Get the weekly health signal without the wellness fog.
A clean weekly brief covering longevity science, fitness, nutrition, medicine, health culture, and the claims worth questioning.
No spam. No selling your information. Unsubscribe anytime.
By subscribing, you agree to receive email from Viral Vitalism. Unsubscribe anytime. See our Privacy Policy.
